Dr. Steven Edward Coutre MD?
Update this Profile
Dr. Steven Edward Coutre MD, Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Steven Edward Coutre MD

Hematologist (Blood Specialist) | Hematology

5/5(8)
875 Blake Wilbur Dr Stanford University Palo Alto CA, 94304
Write A Review
Rating

5/5

About

Dr. Steven Coutre is a hematology internist practicing in Palo Alto, CA. Dr. Coutre specializes in cases of suspected blood disorders when a diagnosis is unclear and further medical care is needed. Hematology internists work with other specialists such as surgeons, radiation therapists and gynecologists in order to get a better understanding on the cases. Often, patients are asked to participate in clinical research that could result in more efficient treatment methods.

Education and Training

Stanford University School of Medicine 1986

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Hematology

Provider Details

MaleEnglish 32 years of experience

Expert Publications

Data provided by the National Library of Medicine

Clinical Trials

Awards

  • Jr. Award for Excellence in Clinical Teaching, Stanford University 1990 Timothy F. Beckett 
  • Stanford University 1991 Bernard Cohen Postdoctoral Fellowship 
  • Stanford University 2002 Division Teaching Award 

Treatments

  • Multiple Myeloma, Blood Disorders, Leukemia And More
  • Anemia
  • Acute Myeloid Leukemia (aml)
  • Lymphoma
  • Multiple Myeloma
  • Leukemia
  • Dermal Aesthetics
  • Oral Surgery Procedures
  • Extra Corporeal Shockwave Therapy

Fellowships

  • Stanford University School of Medicine CA    1992
  • Stanford University Hematology    1992
  • Stanford University School of Medicine,Stanford, Ca, United States   1992

Publications

  • NEW ENGLAND JOURL OF MEDICINETargeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia2013
  • JOURL OF CLINICAL ONCOLOGYPhase I Trial of Anti-CD22 Recombint Immunotoxin Moxetumomab Pasudotox2012
  • Jourl of the tiol Comprehensive Cancer NetworkOptimizing therapy for acute myeloid leukemia.2008
  • BLOODActivity of the tyrosine kise inhibitor PKC4122005
  • BLOODThe HP1L1-PDIGFR alpha fusion tyrosine kise in hypereosinophilic syndrome2004
  • NEW ENGLAND JOURL OF MEDICINEA tyrosine kise created by fusion of the PDGFRA2003
  • Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia, version 2.2013.2013
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines2013
  • HaematologicaSequential azacitidine plus lelidomide combition2013
  • JOURL OF CLINICAL ONCOLOGYHigh-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed2013
  • AMERICAN JOURL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia Clinical Practice Guidelines in Oncology2012
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Lymphoblastic Leukemia2012
  • LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for2012
  • LEUKEMIA & LYMPHOMAFil results of a multicenter phase 1 study of lelidomide2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURLTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURLPhase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B2012
  • AMERICAN JOURL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia2011
  • BRITISH JOURL OF HAEMATOLOGYSouthwest Oncology Group Study S05302010
  • Wendtner, C., Hillmen, P., Mahadevan, D., Stilgenbauer, S., Uharek, L.Fil Results of the Phase I Study of Lelidomide In Patients with Relapsed2010
  • AMERICAN JOURL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
  • JOURL OF CLINICAL ONCOLOGYPhase I and Pharmacologic Study of SNS-0322010
  • BRITISH JOURL OF HAEMATOLOGYExpanded safety experience with lelidomide plus dexamethasone in relapsed or refractory multiple2009
  • Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia.2008
  • LEUKEMIAIntertiol standardized approach for flow cytometric residual disease monitoring in chronic2007
  • AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGYVon Willebrand disease presenting as recurrent hemorrhage after transvagil oocyte retrieval2007
  • BRITISH JOURL OF HAEMATOLOGYMinimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?2007
  • Jourl of the tiol Comprehensive Cancer NetworkAcute myeloid leukemia clinical practice guidelines in oncology.2006
  • LEUKEMIAThe evolving role of alemtuzumab in magement of patients with CLL2005
  • BLOODTherapeutic efficacy2004
  • CLINICAL LYMPHOMAMagement guidelines for use of alemtuzumab in B-Cell chronic lymphocytic leukemia2004
  • SEMIRS IN CANCER BIOLOGYTargeted treatment of hypereosinophilic syndromes2004
  • Current hematology reportsMagement of advanced chronic lymphocytic leukemia.2003
  • JOURL OF CLINICAL ONCOLOGYCampath-1H treatment of T2002
  • TURECONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING1995
  • NEW ENGLAND JOURNAL OF MEDICINETargeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia2013
  • LANCET ONCOLOGYOral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients2012
  • JOURNAL OF CLINICAL ONCOLOGYPhase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox2012
  • BLOODArsenic trioxide improves event-free2010
  • Journal of the National Comprehensive Cancer NetworkOptimizing therapy for acute myeloid leukemia.2008
  • BLOODDasatinib induces rapid hematologic2007
  • BLOODNelarabine induces complete remissions in adults with relapsed or refractory T2007
  • BLOODDasatinib induces complete hematologic2007
  • BLOODActivity of the tyrosine kinase inhibitor PKC4122005
  • BLOODThe HP1L1-PDIGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome2004
  • NEW ENGLAND JOURNAL OF MEDICINEA tyrosine kinase created by fusion of the PDGFRA2003
  • Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia, version 2.2013.2013
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines2013
  • HaematologicaSequential azacitidine plus lenalidomide combination2013
  • CANCERTreatment of adults with acute lymphoblastic leukemia2013
  • JOURNAL OF CLINICAL ONCOLOGYHigh-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed2013
  • AMERICAN JOURNAL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia Clinical Practice Guidelines in Oncology2012
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Lymphoblastic Leukemia2012
  • LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide2012
  • LEUKEMIA & LYMPHOMAFinal results of a multicenter phase 1 study of lenalidomide2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNALTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B2012
  • AMERICAN JOURNAL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
  • BLOODResults from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with2011
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKAcute Myeloid Leukemia2011
  • BLOODCD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies2011
  • MYCOSESYield of diagnostic procedures for invasive fungal infections2011
  • BRITISH JOURNAL OF HAEMATOLOGYSouthwest Oncology Group Study S05302010
  • Wendtner, C., Hillmen, P., Mahadevan, D., Stilgenbauer, S., Uharek, L.Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed2010
  • AMERICAN JOURNAL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
  • CLINICAL LYMPHOMA MYELOMA & LEUKEMIAClassification and Risk Stratification for Acute Promyelocytic Leukemia2010
  • JOURNAL OF CLINICAL ONCOLOGYPhase I and Pharmacologic Study of SNS-0322010
  • BRITISH JOURNAL OF HAEMATOLOGYExpanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple2009
  • LEUKEMIAEfficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid2008
  • Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia.2008
  • GYNECOLOGIC ONCOLOGYAcute postoperative thrombotic thrombocytopenic purpura following hysterectomy2007
  • LEUKEMIAInternational standardized approach for flow cytometric residual disease monitoring in chronic2007
  • AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYVon Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval2007
  • BRITISH JOURNAL OF HAEMATOLOGYMinimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?2007
  • UROLOGYRefractory hematuria from amyloidosis successfully treated by splenectomy2006
  • Journal of the National Comprehensive Cancer NetworkAcute myeloid leukemia clinical practice guidelines in oncology.2006
  • LEUKEMIAThe evolving role of alemtuzumab in management of patients with CLL2005
  • BLOODTherapeutic efficacy2004
  • CLINICAL LYMPHOMAManagement guidelines for use of alemtuzumab in B-Cell chronic lymphocytic leukemia2004
  • SEMINARS IN CANCER BIOLOGYTargeted treatment of hypereosinophilic syndromes2004
  • CANCER CELLPKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFR alpha2003
  • HematologyT-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).2003
  • Current hematology reportsManagement of advanced chronic lymphocytic leukemia.2003
  • CLINICAL LYMPHOMACytomegalovirus viremia during Campath-1H therapy for relapsed2002
  • Sawyers, C. L., Hochhaus, A., Feldman, E., Goldman, J. M., Miller, C. Imatinib induces hematologic2002
  • JOURNAL OF CLINICAL ONCOLOGYCampath-1H treatment of T2002
  • Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian,United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia2001
  • ONCOLOGY-NEW YORKNCCN Practice Guidelines for acute myelogenous leukemia2000
  • NATURECONVERSION OF THROMBIN INTO AN ANTICOAGULANT BY PROTEIN ENGINEERING1995

Experience & Accolades

  • Professor of Medicine (Hematology)the Stanford University Medical Center
  • MemberLeukemia Committee -- Vice Chair
  • Member Disease Management Group Leader-Hematology
  • Associate Director 2009 - 2011 Internal Medicine Residency program, Stanford University
  • Vice Chair 2011 - 2014 Clinical Affairs, Department of Medicine
  • Member2010 - 2014 Stanford Hospital and Clinics
  • Member1998 - 2014 Acute Myeloid Leukemia Panel, National Comprehensive Cancer Network
  • Member2012 - 2014 Acute Lymphoblastic Leukemia Panel, National Comprehensive Cancer Network
  • Member1996 - 2014 Southwest Oncology Group
  • Director1996 - 2014 Hematology Clinic, Stanford University

Dr. Steven Edward Coutre MD's Practice location

Dr. Steven Coutre, MD

875 Blake Wilbur Dr Stanford University -
Palo Alto, CA 94304
Get Direction
New patients: 650-723-6661

Dr. Steven Edward Coutre MD's reviews

(8)
Write Review

Patient Experience with Dr. Coutre


5.0

Based on 8 reviews

Dr. Steven Edward Coutre MD has a rating of 5 out of 5 stars based on the reviews from 8 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist (Blood Specialist) in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

  • Potential Causes of Leukopenia

    IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

  • 5 Foods to Eat When you Have Anemia

    Anemia refers to a state where the body witnesses a decrease in the number of circulating red blood cells causing symptoms like paleness of skin, lethargicness, headache and chest pain. Termed as the most common blood disorder, anemia is strictly not a disease, but a disorder that is often a...

  • Prednisone Side Effects

    PrednisonePrednisone is a corticosteroid, which prevents the release of substances in the body that lead to inflammation. It can also suppress the immune system. Prednisone can be used as an immunosuppressant or an anti-inflammatory drug. A number of conditions can be treated with prednisone. They...

  • Can My Period Be the Cause of My Anemia?

    Anemia is sometimes more commonly referred to as low iron because its root cause is less iron being produced by the body. There are staggering numbers of people increasing in the world every year who are under the torment of this notorious disease. The basic dysfunction starts within the red blood...

  • Cyclist Battles Back from Lymphoma to Make Professional Debut

    In October of 2015, 16-year-old Zack Gilmore felt a lump behind his ear after finishing a cycling training session. He went to the doctor to find out what it was and, three days later, he received the dreadful news: a non-Hodgkin’s lymphoma diagnosis. Gilmore began chemotherapy right away at the...

  • Reasons Why You Need a Biopsy

    OverviewA biopsy is a procedure that involves the removal of a sample tissue in the body to examine it closely under a microscope. The tissue is mainly examined to diagnose a certain disease. Some may use a needle or surgical methods to remove any lumps or suspicious nodules in the body. Some...

Nearby Providers

See all nearby providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head north on Blake Wilbur Drive 440 ft
Turn left onto Welch Road 1270 ft
Turn left onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

1765 ftSee direction

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head north on Blake Wilbur Drive 413 ft
Turn right onto Welch Road 1607 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

3.0 miSee direction

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head north on Blake Wilbur Drive 413 ft
Turn right onto Welch Road 788 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left

1619 ftSee direction